Impact of leading presenting symptoms on the diagnostic performance of high-sensitivity cardiac troponin T and on outcomes in patients with suspected acute coronary syndrome

Clinical Chemistry
Moritz BienerEvangelos Giannitsis

Abstract

Diagnostic performance of high-sensitivity cardiac troponin T (hs-cTnT) varies depending on presenting symptoms in patients with suspected acute coronary syndrome (ACS). We compared performance measures of hs-cTnT among patients admitted to the emergency department with typical chest pain (angina), dyspnea, and atypical symptoms and assessed outcomes by leading presenting symptoms. A total of 658 patients suspected of ACS and presenting with typical chest pain (n = 241, 36.6%), dyspnea (n = 142, 21.6%), or atypical symptoms (n = 275, 41.8%) were included. Diagnostic accuracy of hs-cTnT on admission was higher among patients with typical chest pain compared to those with atypical symptoms [area under the curve (AUC) 0.823 vs AUC 0.776 vs AUC 0.705, P > 0.05 and P = 0.04]. Absolute concentration changes within 6 h improved accuracy among all subgroups, with the smallest added benefit in typical chest pain and dyspnea (ΔAUC, 0.078; P = 0.02 and 0.05, P > 0.05). During 1-year follow-up, dyspnea was associated with a higher risk of death (hazard ratio, 2.36; 95% CI, 1.26-4.43, P = 0.008) and death/AMI (hazard ratio, 2.23; 95% CI, 1.21-4.11, P = 0.01) compared to typical chest pain. Optimal discriminating values for hs-cTnT were high...Continue Reading

References

Jul 20, 2002·The American Journal of Cardiology·John G CantoNorman W Weissman
Dec 18, 2002·American Heart Journal·Viktor CulićNardi Silić
Jun 5, 2004·Progress in Cardiovascular Diseases·Raghunandan Kamineni, Joseph S Alpert
Nov 9, 2005·Journal of the American Geriatrics Society·Roy L SoizaAllister D Hargreaves
Apr 22, 2009·Clinical Cardiology·Aleksander GochMaciej Banach
May 22, 2009·The New England Journal of Medicine·Shamir R MehtaUNKNOWN TIMACS Investigators
Jul 7, 2009·The American Journal of Cardiology·Usman JavedDeepak Thatai
Aug 28, 2009·The New England Journal of Medicine·Tobias ReichlinChristian Mueller
Aug 28, 2009·The New England Journal of Medicine·Till KellerStefan Blankenberg
Dec 5, 2009·Clinical Chemistry·Evangelos GiannitsisHugo A Katus
Jan 12, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·A K SaengerA S Jaffe
May 24, 2011·The American Journal of Medicine·Edward O McFallsPatricia L Sinnott
Dec 29, 2011·JAMA : the Journal of the American Medical Association·Till KellerStefan Blankenberg
Aug 16, 2012·Archives of Internal Medicine·Tobias ReichlinChristian Mueller
Aug 28, 2012·European Heart Journal·Kristian ThygesenUNKNOWN ESC Committee for Practice Guidelines (CPG)
Jul 23, 2013·The American Journal of Medicine·Affan IrfanChristian Mueller
Aug 28, 2013·Nature Reviews. Cardiology·Evangelos Giannitsis, Hugo A Katus
Jun 27, 2014·European Heart Journal. Acute Cardiovascular Care·Yader SandovalFred S Apple
Jun 1, 2014·Turkish Journal of Emergency Medicine·Ahmet Tugrul ZeytinHamit Ozcelik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.